WASHINGTON, D.C. — Avengers: Endgame Encore pulled $86 million worldwide this weekend, with $26 million in North America and $60 million overseas, pushing the 2019 blockbuster’s cumulative gross to $2.88 billion.

Meanwhile, Brad Pitt’s new thriller ‘Heart of the Beast’ opened to $50 million globally, $18 million of which came from the United States. The film’s strong opening underscores the continued appetite for star‑driven, mid‑budget releases amid a market dominated by franchise tentpoles, offering investors a diversified revenue stream beyond blockbuster tentacles.

Disney’s shares rose 1.3 percent after the encore performance, as analysts noted the added $86 million narrows the gap to the all‑time leader ‘Avatar,’ which sits $39 million ahead. The incremental box‑office cash improves the company’s cash‑flow outlook for the quarter, supporting its ongoing investment in theme‑park expansions and the rollout of its ad‑supported streaming tier.

The re‑release also highlights the impact of recent policy changes to the theatrical‑window exemption, which allow studios to shorten the gap between cinema and streaming. Regulators in the EU are reviewing whether such exemptions give major studios an unfair advantage, a debate that could shape future distribution contracts and affect global box‑office forecasts.

“The encore shows the enduring power of legacy IP to generate incremental revenue with minimal additional cost,” said Maria Lopez, senior analyst at Global Equity Research. “Investors should watch how Disney leverages these windfalls to fund its broader content pipeline, especially as competition from streaming rivals intensifies.”

Key Takeaways

• Endgame’s encore adds $86 million, lifting total to $2.88 billion, just $39 million behind the record holder.
• Brad Pitt’s ‘Heart of the Beast’ demonstrates viable box‑office returns for mid‑budget films, reaching $50 million worldwide.
• Policy discussions on theatrical‑window exemptions may influence future revenue models and investor risk assessments.

As the industry balances blockbuster re‑releases with new mid‑budget offerings, the latest figures provide a snapshot of revenue diversification. Stakeholders—from studio executives to regulators and shareholders—will monitor how these earnings translate into longer‑term financial health and whether policy shifts reshape the theatrical ecosystem.